HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#141 / 200 Total
AEVA - Aeva Technologies Inc - Stock Price Chart
TickerAEVA [NASD, RUT]
CompanyAeva Technologies Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap1.70BEPS (ttm)-2.82
P/E-EPS this Y17.24%
Forward P/E-EPS next Y6.57%
PEG-EPS past 5Y-678.17%
P/S164.48EPS next 5Y18.15%
P/B24.66EPS Q/Q4.93%
Dividend-Sales Q/Q59.85%
Insider Own43.28%Inst Own48.81%
Insider Trans23.71%Inst Trans75.03%
Short Float15.60%EarningsMay 14/a
Analyst Recom1.40Target Price18.60
Avg Volume2.22M52W Range2.20 - 38.80
Today 12:30PM Ouster Rallies 77% YTD, Outperforms Industry: Time to Buy the Stock? (Zacks) +7.75%
09:38AM Aeva & Mobileye: LiDAR Stocks Powering the Autonomous Revolution (MarketBeat)
Jul-01-25 06:52AM Profits Are Optional Again (The Wall Street Journal) -24.16%
Jun-30-25 04:07AM Strength Seen in Aeva Technologies (AEVA): Can Its 8.6% Jump Turn into More Strength? (Zacks)
Jun-28-25 10:24AM Aeva Technologies (AEVA) Rallies 8.55% on Robotics, Autonomous Driving Growth Opportunities (Insider Monkey)
Jun-26-25 09:45AM LiDAR's Future: AEVA or OUST - Which Stock Shines Brighter? (Zacks) +15.05%
07:00AM Aeva to Unveil Vision for the Future of Sensing and Perception at "Aeva Day: Beyond the Beam" Event (Business Wire)
Jun-19-25 07:44AM AEVA Steps Into ITS - Is This the Next Growth Frontier? (Zacks)
Jun-12-25 08:25AM AEVA at 52-Week High - But Is the Premium Valuation Justified? (Zacks)
Jun-11-25 07:00AM Aeva Achieves TISAX AL2 Certification, Strengthening Commitment to Automotive Information Security (Business Wire)
ARBB - ARB IOT Group Ltd - Stock Price Chart
TickerARBB [NASD]
CompanyARB IOT Group Ltd
CountrySingapore
IndustryInformation Technology Services
Market Cap10.95MEPS (ttm)-0.27
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.45EPS next 5Y-
P/B3.11EPS Q/Q51.89%
Dividend-Sales Q/Q175.31%
Insider Own15.04%Inst Own0.70%
Insider Trans0.00%Inst Trans-
Short Float0.65%Earnings-
Analyst Recom1.00Target Price20.00
Avg Volume108.47K52W Range3.22 - 18.60
May-29-25 08:00AM ARB IOT Group Limited Announces 1-for-15 Reverse Share Split (GlobeNewswire) -14.91%
Apr-15-25 11:41PM ARB IOT Group (ARBB): Lands $53M AI Server Deal, 3x Its Market Cap (Insider Monkey) +42.51% -22.60%
Apr-14-25 04:30PM ARB IOT Group Limited Secures Approximately USD53.0 Million Order for Supplying AI Servers (GlobeNewswire) +22.26%
Apr-03-25 04:00PM ARB IOT Group Limited Introduces AI Drone Technology to Revolutionise Plantation Management (GlobeNewswire) -8.52%
Mar-27-25 04:00PM ARB IOT Group Limited Unveils Cutting-Edge Smart AI Robot to Revolutionize Fertilization in Agriculture (GlobeNewswire) +10.00%
Mar-20-25 04:00PM ARB IOT Group Limited Secures Additional Order for Its Smart IOT Palm Farming System, Strengthening Market Presence in Sabah (GlobeNewswire) +14.05%
Mar-11-25 04:30PM ARB IOT Group Limited Secures Yearly Recurring Order of Approximately USD20 Million in Smart IoT Palm Farming Business in Sabah (GlobeNewswire) -25.16%
04:00PM ARB IOT Group Limited Appointed Exclusive Wholesaler, Distributor and System Integrator for Its Smart IoT Palm Farming Solutions to Gain Market Access in Sabah and Sarawak Regions (GlobeNewswire)
Mar-07-25 07:11PM ARB IOT Group Limited (ARBB) Secures $45M AI Server Deal to Expand in Data Center Market (Insider Monkey) +26.14%
04:00PM ARB IOT GROUP LIMITED EXPANDS AI FOOTPRINT INTO EAST MALAYSIA (GlobeNewswire)
SION - Sionna Therapeutics Inc - Stock Price Chart
TickerSION [NASD]
CompanySionna Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap920.88MEPS (ttm)-
P/E-EPS this Y83.43%
Forward P/E-EPS next Y-8.40%
PEG-EPS past 5Y-
P/S-EPS next 5Y40.90%
P/B2.62EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own46.56%Inst Own54.07%
Insider Trans20.75%Inst Trans39.33%
Short Float11.99%EarningsMay 12/b
Analyst Recom1.00Target Price38.50
Avg Volume179.81K52W Range7.26 - 25.19
Jun-06-25 11:00AM Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model (GlobeNewswire) +7.42%
Jun-04-25 01:54PM Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial (Benzinga) +9.12%
07:00AM Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis (GlobeNewswire)
Jun-03-25 07:00AM Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
May-22-25 07:00AM Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference (GlobeNewswire)
May-12-25 07:00AM Sionna Therapeutics Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-30-25 07:00AM Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025 (GlobeNewswire)
Mar-20-25 07:00AM Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-15-25 04:43PM Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month (Insider Monkey)
Mar-06-25 10:25AM Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently? (Insider Monkey) -5.04%
GHG - GreenTree Hospitality Group Ltd ADR - Stock Price Chart
TickerGHG [NYSE]
CompanyGreenTree Hospitality Group Ltd ADR
CountryChina
IndustryLodging
Market Cap162.89MEPS (ttm)0.16
P/E15.57EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-24.85%
P/S0.87EPS next 5Y-
P/B0.82EPS Q/Q-770.55%
Dividend4.10%Sales Q/Q-17.73%
Insider Own-Inst Own10.07%
Insider Trans-Inst Trans-3.29%
Short Float-EarningsApr 24/b
Analyst Recom3.00Target Price3.62
Avg Volume23.04K52W Range1.93 - 3.40
Apr-30-25 05:24PM GreenTree Filed Annual Report on Form 20-F for Fiscal Year 2024 (PR Newswire) +6.86%
Apr-25-25 11:32AM GreenTree Hospitality Group Ltd. (GHG) Q4 2024 Earnings Call Transcript (Seeking Alpha)
Apr-24-25 07:38AM GreenTree Hospitality Group Ltd. Reports Fourth Quarter and Fiscal Year 2024 Financial Results (PR Newswire)
Apr-22-25 10:29AM GreenTree to Report Fourth Quarter and Fiscal Year 2024 Financial Results on April 24, 2025 (PR Newswire)
Nov-26-24 06:50AM GreenTree Hospitality Reports Revenue Decline Amid Expansion Efforts (TipRanks)
Nov-22-24 02:02AM GreenTree Hospitality Group Ltd (GHG) Q3 2024 Earnings Call Highlights: Navigating Challenges ... (GuruFocus.com)
Nov-21-24 11:27PM Q3 2024 GreenTree Hospitality Group Ltd Earnings Call (Thomson Reuters StreetEvents)
07:19AM GreenTree Hospitality Group Ltd. Reports Third Quarter of 2024 Financial Results (PR Newswire)
Nov-18-24 11:26PM GreenTree to Report Third Quarter 2024 Financial Results on November 21, 2024 (PR Newswire)
Oct-01-24 08:35AM GreenTree Hospitality Group Ltd. (GHG) Returns to Profitability in Q2 2024 (Insider Monkey)
PGEN - Precigen Inc - Stock Price Chart
TickerPGEN [NASD, RUT]
CompanyPrecigen Inc
CountryUSA
IndustryBiotechnology
Market Cap475.24MEPS (ttm)-0.57
P/E-EPS this Y25.00%
Forward P/E-EPS next Y88.65%
PEG-EPS past 5Y25.76%
P/S113.15EPS next 5Y-
P/B-EPS Q/Q-93.59%
Dividend-Sales Q/Q25.92%
Insider Own50.41%Inst Own27.33%
Insider Trans0.00%Inst Trans6.06%
Short Float18.64%EarningsMay 14/a
Analyst Recom2.00Target Price6.00
Avg Volume1.66M52W Range0.65 - 2.17
May-14-25 04:05PM Precigen Reports First Quarter 2025 Financial Results and Business Updates (PR Newswire) -5.19%
Apr-22-25 12:00PM Patient Capital Management Q1 2025 Investment Review (Seeking Alpha) +11.68%
Apr-16-25 08:05AM Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th (PR Newswire)
Mar-27-25 10:19AM Is Precigen (PGEN) The Hot Biotech Stock Under $5? (InsiderMonkey)
Mar-21-25 06:23PM Precigen Inc (PGEN) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-19-25 07:47PM Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript (SeekingAlpha) +7.19%
06:25PM Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM Precigen Reports Full Year 2024 Financial Results and Business Updates (PR Newswire)
Mar-13-25 08:05AM Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th (PR Newswire)
Mar-01-25 05:27PM Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025 (Insider Monkey)
SVRE - SaverOne 2014 Ltd ADR - Stock Price Chart
TickerSVRE [NASD]
CompanySaverOne 2014 Ltd ADR
CountryIsrael
IndustryScientific & Technical Instruments
Market Cap0.88MEPS (ttm)-288.36
P/E-EPS this Y-983.02%
Forward P/E-EPS next Y13.16%
PEG-EPS past 5Y38.93%
P/S1.96EPS next 5Y-
P/B0.08EPS Q/Q79.01%
Dividend-Sales Q/Q-1.67%
Insider Own-Inst Own9.05%
Insider Trans-Inst Trans-
Short Float-EarningsMar 21/a
Analyst Recom1.00Target Price19.50
Avg Volume1.21M52W Range2.10 - 325.43
Jun-18-25 08:30AM SaverOne Granted New US Patent Advancing Sensor Fusion Capabilities for Driver Safety (GlobeNewswire)
Jun-17-25 09:00AM SaverOne 2014 signs preliminary agreement with ADAS technology provider (TipRanks) -10.04%
Jun-16-25 08:56AM SaverOne Signs Preliminary Agreement with Leading European ADAS Technology Provider for Sensor Fusion Collaboration (GlobeNewswire)
Jun-09-25 08:30AM SaverOne Further Broadens its Global Expansion with a new Agreement with CEMEX Germany (GlobeNewswire) -9.17%
Apr-21-25 08:30AM SaverOne Signs Expands Cooperation with Cemex: Signs Agreement with Cemex Czech Republic for Deployment of Its Driver Distraction Prevention System (GlobeNewswire)
Apr-16-25 08:30AM SaverOne Signs New Distribution Agreement in Canada (GlobeNewswire) -12.98%
Mar-21-25 04:50PM SaverOne Reports Full Year 2024 Results (GlobeNewswire) -10.51%
Mar-17-25 08:10AM SaverOne Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) -9.62%
Feb-24-25 08:00AM SaverOne Granted New Patent in the United States Further Expanding its IP Portfolio (GlobeNewswire)
Feb-21-25 05:05PM SaverOne Implements Change in Ratio of Shares to ADSs to Meet Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
ALT - Altimmune Inc - Stock Price Chart
TickerALT [NASD, RUT]
CompanyAltimmune Inc
CountryUSA
IndustryBiotechnology
Market Cap397.42MEPS (ttm)-1.25
P/E-EPS this Y5.69%
Forward P/E-EPS next Y-24.49%
PEG-EPS past 5Y3.48%
P/S19871.06EPS next 5Y0.61%
P/B2.68EPS Q/Q24.79%
Dividend-Sales Q/Q0.00%
Insider Own1.04%Inst Own47.38%
Insider Trans1.32%Inst Trans-5.65%
Short Float30.40%EarningsMay 13/b
Analyst Recom1.22Target Price22.38
Avg Volume4.97M52W Range2.90 - 11.16
Jun-26-25 07:00AM Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH (GlobeNewswire) -53.18%
Jun-25-25 07:12PM Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26 (GlobeNewswire) +7.23%
Jun-18-25 09:53AM Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside. (Motley Fool)
Jun-13-25 07:30AM Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association's Scientific Sessions (GlobeNewswire)
May-21-25 11:17AM Could Altimmune, Inc. (ALT): Analysts See 288% Upside Potential (Insider Monkey)
May-19-25 07:30AM Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD) (GlobeNewswire)
May-14-25 09:18AM Morning Movers: UnitedHealth sinks following CEO exit and outlook suspension (TipRanks)
07:30AM Altimmune to Participate at Two Upcoming Investor Conferences (GlobeNewswire)
May-13-25 07:00AM Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital (GlobeNewswire)
07:00AM Altimmune Announces First Quarter 2025 Financial Results and Business Update (GlobeNewswire)
TOI - Oncology Institute Inc - Stock Price Chart
TickerTOI [NASD]
CompanyOncology Institute Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap224.27MEPS (ttm)-0.70
P/E-EPS this Y46.48%
Forward P/E-EPS next Y76.32%
PEG-EPS past 5Y-488.57%
P/S0.56EPS next 5Y-
P/B42.81EPS Q/Q4.88%
Dividend-Sales Q/Q10.29%
Insider Own50.33%Inst Own14.73%
Insider Trans-6.44%Inst Trans4.55%
Short Float5.27%EarningsMay 14/a
Analyst Recom1.00Target Price7.00
Avg Volume1.80M52W Range0.13 - 3.50
Jun-30-25 04:05PM The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada (GlobeNewswire) -6.39% +7.32%
Jun-03-25 08:00AM The Oncology Institute set to join the Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 04:06PM The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance (GlobeNewswire) -10.57% +28.27%
04:05PM The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer (GlobeNewswire)
May-13-25 07:08PM Topicus.com Inc. Announces Election of Members of the Board of Directors (GlobeNewswire)
04:05PM The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference (GlobeNewswire)
May-08-25 08:00AM The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates (GlobeNewswire) +6.18%
May-07-25 05:03PM Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025 (GlobeNewswire) +5.36%
May-01-25 05:48PM Topicus.com Inc. Defers Release Date for First Quarter Results (GlobeNewswire) +12.50%
Apr-30-25 06:04AM Why The Oncology Institute, Inc. (TOI) is Surging in 2025 (Insider Monkey)
LCFY - Locafy Limited - Stock Price Chart
TickerLCFY [NASD]
CompanyLocafy Limited
CountryAustralia
IndustryInternet Content & Information
Market Cap8.28MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y0.15%
P/S-EPS next 5Y-
P/B3.75EPS Q/Q97.32%
Dividend-Sales Q/Q-62.43%
Insider Own20.72%Inst Own1.29%
Insider Trans0.00%Inst Trans47.66%
Short Float0.08%Earnings-
Analyst Recom-Target Price-
Avg Volume1.61M52W Range2.28 - 13.98
Jun-27-25 08:00AM Locafy Partners with Leading U.S. Reputation Platform - Plans to Scale Deployment of "AI-Ready" Search Solutions (GlobeNewswire) +225.49%
Apr-04-25 08:35AM AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing (GlobeNewswire) -13.26%
Apr-01-25 09:24AM Locafy to Present at the AI & Technology Virtual Investor Conference April 3rd (GlobeNewswire)
09:08AM AI & Technology Virtual Investor Conference Agenda Announced for April 3rd (GlobeNewswire)
Feb-19-25 08:00AM Locafy Limited Highlights Growth and Strategic Partnerships in Recent Investor Presentations (GlobeNewswire)
Feb-13-25 08:00AM Locafy Introduces Localizer, a Powerful Solution to Boost Local Search Visibility and Drive Partner-Led Growth (GlobeNewswire) +11.18%
Jan-30-25 08:30AM Fathom Holdings Partners with Locafy Limited to Boost Real Estate Agents' Visibility in Local Search Results (PR Newswire) +15.70%
Jan-21-25 09:00AM Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE)
Jan-17-25 08:00AM Locafy Launches Strategic Partner Program with Announcement of Unique Point Partnership and Highlights Resellers Transitioning to Strategic Partner Program (GlobeNewswire)
Dec-19-24 08:30AM Locafy Unveils 2025 Product Roadmap: AI-Powered Publishing Solutions to Potentially Revolutionize Local SEO (GlobeNewswire)
VYNE - VYNE Therapeutics Inc - Stock Price Chart
TickerVYNE [NASD]
CompanyVYNE Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap25.17MEPS (ttm)-0.99
P/E-EPS this Y-10.22%
Forward P/E-EPS next Y28.29%
PEG-EPS past 5Y65.87%
P/S41.94EPS next 5Y11.71%
P/B0.55EPS Q/Q-37.65%
Dividend-Sales Q/Q106.12%
Insider Own18.32%Inst Own36.72%
Insider Trans0.49%Inst Trans1.45%
Short Float2.53%EarningsMay 08/b
Analyst Recom1.00Target Price6.38
Avg Volume514.78K52W Range0.85 - 4.30
Today 07:45AM VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202 (GlobeNewswire) -14.69%
May-08-25 08:00AM VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update (GlobeNewswire) -5.11%
Apr-25-25 08:00AM VYNE Therapeutics Provides Update on VYN202 Program (GlobeNewswire) -23.94%
Mar-20-25 08:00AM VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference (GlobeNewswire) -5.08%
Mar-06-25 08:00AM VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update (GlobeNewswire)
Feb-20-25 08:00AM VYNE Therapeutics to Participate in March Investor Conferences (GlobeNewswire) +7.14%
Feb-19-25 08:00AM VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis (GlobeNewswire)
Jan-06-25 07:30AM VYNE Therapeutics Completes Enrollment in Phase 2b Trial Evaluating VYN201 for the Treatment of Nonsegmental Vitiligo (GlobeNewswire) +15.61%
Dec-24-24 09:51AM H.C. Wainwright says VYNEs VYN202 becomes pick of the crop after MAD data (TipRanks) +15.56%
Dec-23-24 07:30AM VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor (GlobeNewswire)
1⋯1011121314151617181920
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.